BRUNETTO, MAURIZIA ROSSANA Statistiche
BRUNETTO, MAURIZIA ROSSANA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent - A Critical Reasoning
2022-01-01 Consolini, Rita; Costagliola, G; Spada, E; Colombatto, P; Orsini, A; Bonuccelli, Alice; Brunetto, Mr; Peroni, Diego
Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
2022-01-01 Rognoni, Carla; Barcellona, Maria Rosa; Bargellini, Irene; Bavetta, Maria Grazia; Bellò, Marilena; Brunetto, Maurizia; Carucci, Patrizia; Cioni, Roberto; Crocetti, Laura; D'Amato, Fabio; D'Amico, Mario; Deagostini, Simona; Deandreis, Désirée; De Simone, Paolo; Doriguzzi, Andrea; Finessi, Monica; Fonio, Paolo; Grimaldi, Serena; Ialuna, Salvatore; Lagattuta, Fabio; Masi, Gianluca; Moreci, Antonio; Scalisi, Daniele; Virdone, Roberto; Tarricone, Rosanna
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
2022-01-01 Colombatto, Piero; Palmisano, Elena; Ricco, Gabriele; Cavallone, Daniela; Oliveri, Filippo; Coco, Barbara; Salvati, Antonio; Romagnoli, Veronica; Surace, Lidia; Vatteroni, Marialinda; Pistello, Mauro; Virdis, Agostino; Bonino, Ferruccio; Brunetto, Maurizia Rossana
Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral18 FDG in Mice
2022-01-01 Guzzardi, M. A.; La Rosa, F.; Campani, D.; Cacciato Insilla, A.; Nannipieri, M.; Brunetto, M. R.; Bonino, F.; Iozzo, P.
Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer’s Disease Mouse Model
2022-01-01 Guzzardi, M. A.; La Rosa, F.; Campani, D.; Collado, M. C.; Monleon, D.; Insilla, A. C.; Tripodi, M.; Zega, A.; Dattilo, A.; Brunetto, M. R.; Maffei, M.; Bonino, F.; Iozzo, P.
Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases
2022-01-01 Bocci, Guido; Orlandi, Paola; Manca, MARIA LAURA; Rossi, Chiara; Salvati, Antonio; Brunetto, MAURIZIA ROSSANA; Solini, Anna
Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases
2022-01-01 Bocci, Guido; Orlandi, Paola; Manca, Maria Laura; Rossi, Chiara; Salvati, Antonio; Brunetto, Maurizia Rossana; Solini, Anna
The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage
2022-01-01 Rossi, Chiara; Salvati, Antonio; Distaso, Mariarosaria; Campani, Daniela; Raggi, Francesco; Biancalana, Edoardo; Tricò, Domenico; Brunetto, Maurizia Rossana; Solini, Anna
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
2022-01-01 Puleo, Luciana; Agate, Laura; Bargellini, Irene; Boni, Giuseppe; Piaggi, Paolo; Traino, Claudio; Depalo, Tommaso; Lorenzoni, Giulia; Bianchi, Francesca; Volterrani, Duccio; Brogioni, Sandra; Bottici, Valeria; Brunetto, Maurizia Rossana; Coco, Barbara; Molinaro, Eleonora; Elisei, Rossella
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study.
2021-01-01 Marasco, G; Poggioli, F; Colecchia, A; Cabibbo, G; Pelizzaro, F; Giannini, Eg; Marinelli, S; Rapaccini, Gl; Caturelli, E; Di Marco, M; Biasini, E; Marra, F; Morisco, F; Foschi, Fg; Zoli, M; Gasbarrini, A; Svegliati Baroni, G; Masotto, A; Sacco, R; Raimondo, G; Azzaroli, F; Mega, A; Vidili, G; Brunetto, Mr; Nardone, G; Alemanni, Lv; Dajti, E; Ravaioli, F; Festi, D; Trevisani, F; Italian Liver Cancer Ita Li Ca Group, Obot
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
2021-01-01 An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs., Cordell HJ; Fryett, Jj; Ueno, K; Darlay, R; Aiba, Y; Hitomi, Y; Kawashima, M; Nishida, N; Khor, Ss; Gervais, O; Kawai, Y; Nagasaki, M; Tokunaga, K; Tang, R; Shi, Y; Li, Z; Juran, Bd; Atkinson, Ej; Gerussi, A; Carbone, M; Asselta, R; Cheung, A; de Andrade, M; Baras, A; Horowitz, J; Ferreira, Mar; Sun, D; Jones, De; Flack, S; Spicer, A; Mulcahy, Vl; Byan, J; Han, Y; Sandford, Rn; Lazaridis, Kn; Amos, Ci; Hirschfield, Gm; Seldin, Mf; Invernizzi, P; Siminovitch, Ka; Ma, X; Nakamura, M; Mells, Gf; Pbc, Consortia; Canadian PBC, Consortium; Chinese PBC, Consortium; Italian PBC Study, Group; Brunetto, Mr; Japan-PBC-GWAS, Consortium; US PBC, Consortium; UK-PBC, Consortium.
Antiangiogenic drugs in NASH: Evidence of a possible new therapeutic approach
2021-01-01 Orlandi, P.; Solini, A.; Banchi, M.; Brunetto, M. R.; Cioni, D.; Ghiadoni, L.; Bocci, G.
Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV.
2021-01-01 Pan, Cq; Chang, Tt; Bae, Sh; Brunetto, M; Seto, Wk; Coffin, Cs; Tan, Sk; Mo, S; Flaherty, Jf; Gaggar, A; Nguyen, Mh; Çelen, Mk; Thompson, A; Gane, Ej
Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease.
2021-01-01 Rebelos, E; Iozzo, P; Guzzardi, Ma; Brunetto, Mr; Bonino, F
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort.
2021-01-01 Quaranta, Mg; Ferrigno, L; Tata, X; D'Angelo, F; Massari, M; Coppola, C; Biliotti, E; Giorgini, A; Laccabue, D; Ciancio, A; Blanc, Pl; Margotti, M; Ieluzzi, D; Brunetto, Mr; Barbaro, F; Russo, Fp; Beretta, I; Morsica, G; Verucchi, G; Saracino, A; Galli, M; Kondili, La; PITER Collaborating, Group.
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
2021-01-01 Burra, P; Bizzaro, D; Gonta, A; Shalaby, S; Gambato, M; Morelli, Mc; Trapani, S; Floreani, A; Marra, F; Brunetto, Mr; Taliani, G; Villa, E; Special Interest Group Gender in Hepatology of the Italian Association for the Study of the, Liver
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
2021-01-01 Carr, Bi; Guerra, V; Donghia, R; Farinati, F; Giannini, Eg; Muratori, L; Rapaccini, Gl; Di Marco, M; Caturelli, E; Zoli, M; Sacco, R; Celsa, C; Campani, C; Mega, A; Guarino, M; Gasbarrini, A; Svegliati-Baroni, G; Foschi, Fg; Biasini, E; Masotto, A; Nardone, G; Raimondo, G; Azzaroli, F; Vidili, G; Brunetto, Mr; Trevisani, F.
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis.
2021-01-01 Brunetto, Mr; Carey, I; Maasoumy, B; Marcos-Fosch, C; Boonstra, A; Caviglia, Gp; Loglio, A; Cavallone, D; Scholtes, C; Ricco, G; Smedile, A; Riveiro-Barciela, M; van Bömmel, F; van der Eijk, A; Zoulim, F; Berg, T; Cornberg, M; Lampertico, P; Agarwal, K; Buti, M
MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE METHODS TO IDENTIFY CLINICAL FEATURES PREDICTIVE OF PROGRESSIVE MAFLD
2021-01-01 Salvati, A; De Rosa, L; Salvati, N; Faita, F; Cavallone, D; Ricco, G; Colombatto, P; Coco, B; Romagnoli, V; Oliveri, F; Bonino, F; Brunetto, Mr
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment.
2021-01-01 Cucchetti, A; Gramenzi, A; Johnson, P; Giannini, Eg; Tovoli, F; Rapaccini, Gl; Marra, F; Cabibbo, G; Caturelli, E; Gasbarrini, A; Svegliati-Baroni, G; Sacco, R; Zoli, M; Morisco, F; Di Marco, M; Mega, A; Foschi, Fg; Biasini, E; Masotto, A; Nardone, G; Raimondo, G; Azzaroli, F; Vidili, G; Brunetto, Mr; Farinati, F; Trevisani, F; Italian Liver Cancer, (ITA. LI. CA) Group.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Case Report: MIS-C With Prominent Hepatic and Pancreatic Involvement in a Vaccinated Adolescent - A Critical Reasoning | 1-gen-2022 | Consolini, Rita; Costagliola, G; Spada, E; Colombatto, P; Orsini, A; Bonuccelli, Alice; Brunetto, Mr; Peroni, Diego | |
| Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma | 1-gen-2022 | Rognoni, Carla; Barcellona, Maria Rosa; Bargellini, Irene; Bavetta, Maria Grazia; Bellò, Marilena; Brunetto, Maurizia; Carucci, Patrizia; Cioni, Roberto; Crocetti, Laura; D'Amato, Fabio; D'Amico, Mario; Deagostini, Simona; Deandreis, Désirée; De Simone, Paolo; Doriguzzi, Andrea; Finessi, Monica; Fonio, Paolo; Grimaldi, Serena; Ialuna, Salvatore; Lagattuta, Fabio; Masi, Gianluca; Moreci, Antonio; Scalisi, Daniele; Virdone, Roberto; Tarricone, Rosanna | |
| Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy | 1-gen-2022 | Colombatto, Piero; Palmisano, Elena; Ricco, Gabriele; Cavallone, Daniela; Oliveri, Filippo; Coco, Barbara; Salvati, Antonio; Romagnoli, Veronica; Surace, Lidia; Vatteroni, Marialinda; Pistello, Mauro; Virdis, Agostino; Bonino, Ferruccio; Brunetto, Maurizia Rossana | |
| Evidence of a Gastro-Duodenal Effect on Adipose Tissue and Brain Metabolism, Potentially Mediated by Gut–Liver Inflammation: A Study with Positron Emission Tomography and Oral18 FDG in Mice | 1-gen-2022 | Guzzardi, M. A.; La Rosa, F.; Campani, D.; Cacciato Insilla, A.; Nannipieri, M.; Brunetto, M. R.; Bonino, F.; Iozzo, P. | |
| Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer’s Disease Mouse Model | 1-gen-2022 | Guzzardi, M. A.; La Rosa, F.; Campani, D.; Collado, M. C.; Monleon, D.; Insilla, A. C.; Tripodi, M.; Zega, A.; Dattilo, A.; Brunetto, M. R.; Maffei, M.; Bonino, F.; Iozzo, P. | |
| Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases | 1-gen-2022 | Bocci, Guido; Orlandi, Paola; Manca, MARIA LAURA; Rossi, Chiara; Salvati, Antonio; Brunetto, MAURIZIA ROSSANA; Solini, Anna | |
| Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases | 1-gen-2022 | Bocci, Guido; Orlandi, Paola; Manca, Maria Laura; Rossi, Chiara; Salvati, Antonio; Brunetto, Maurizia Rossana; Solini, Anna | |
| The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage | 1-gen-2022 | Rossi, Chiara; Salvati, Antonio; Distaso, Mariarosaria; Campani, Daniela; Raggi, Francesco; Biancalana, Edoardo; Tricò, Domenico; Brunetto, Maurizia Rossana; Solini, Anna | |
| Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer | 1-gen-2022 | Puleo, Luciana; Agate, Laura; Bargellini, Irene; Boni, Giuseppe; Piaggi, Paolo; Traino, Claudio; Depalo, Tommaso; Lorenzoni, Giulia; Bianchi, Francesca; Volterrani, Duccio; Brogioni, Sandra; Bottici, Valeria; Brunetto, Maurizia Rossana; Coco, Barbara; Molinaro, Eleonora; Elisei, Rossella | |
| A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study. | 1-gen-2021 | Marasco, G; Poggioli, F; Colecchia, A; Cabibbo, G; Pelizzaro, F; Giannini, Eg; Marinelli, S; Rapaccini, Gl; Caturelli, E; Di Marco, M; Biasini, E; Marra, F; Morisco, F; Foschi, Fg; Zoli, M; Gasbarrini, A; Svegliati Baroni, G; Masotto, A; Sacco, R; Raimondo, G; Azzaroli, F; Mega, A; Vidili, G; Brunetto, Mr; Nardone, G; Alemanni, Lv; Dajti, E; Ravaioli, F; Festi, D; Trevisani, F; Italian Liver Cancer Ita Li Ca Group, Obot | |
| An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. | 1-gen-2021 | An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs., Cordell HJ; Fryett, Jj; Ueno, K; Darlay, R; Aiba, Y; Hitomi, Y; Kawashima, M; Nishida, N; Khor, Ss; Gervais, O; Kawai, Y; Nagasaki, M; Tokunaga, K; Tang, R; Shi, Y; Li, Z; Juran, Bd; Atkinson, Ej; Gerussi, A; Carbone, M; Asselta, R; Cheung, A; de Andrade, M; Baras, A; Horowitz, J; Ferreira, Mar; Sun, D; Jones, De; Flack, S; Spicer, A; Mulcahy, Vl; Byan, J; Han, Y; Sandford, Rn; Lazaridis, Kn; Amos, Ci; Hirschfield, Gm; Seldin, Mf; Invernizzi, P; Siminovitch, Ka; Ma, X; Nakamura, M; Mells, Gf; Pbc, Consortia; Canadian PBC, Consortium; Chinese PBC, Consortium; Italian PBC Study, Group; Brunetto, Mr; Japan-PBC-GWAS, Consortium; US PBC, Consortium; UK-PBC, Consortium. | |
| Antiangiogenic drugs in NASH: Evidence of a possible new therapeutic approach | 1-gen-2021 | Orlandi, P.; Solini, A.; Banchi, M.; Brunetto, M. R.; Cioni, D.; Ghiadoni, L.; Bocci, G. | |
| Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV. | 1-gen-2021 | Pan, Cq; Chang, Tt; Bae, Sh; Brunetto, M; Seto, Wk; Coffin, Cs; Tan, Sk; Mo, S; Flaherty, Jf; Gaggar, A; Nguyen, Mh; Çelen, Mk; Thompson, A; Gane, Ej | |
| Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. | 1-gen-2021 | Rebelos, E; Iozzo, P; Guzzardi, Ma; Brunetto, Mr; Bonino, F | |
| Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort. | 1-gen-2021 | Quaranta, Mg; Ferrigno, L; Tata, X; D'Angelo, F; Massari, M; Coppola, C; Biliotti, E; Giorgini, A; Laccabue, D; Ciancio, A; Blanc, Pl; Margotti, M; Ieluzzi, D; Brunetto, Mr; Barbaro, F; Russo, Fp; Beretta, I; Morsica, G; Verucchi, G; Saracino, A; Galli, M; Kondili, La; PITER Collaborating, Group. | |
| Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 1-gen-2021 | Burra, P; Bizzaro, D; Gonta, A; Shalaby, S; Gambato, M; Morelli, Mc; Trapani, S; Floreani, A; Marra, F; Brunetto, Mr; Taliani, G; Villa, E; Special Interest Group Gender in Hepatology of the Italian Association for the Study of the, Liver | |
| Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs. | 1-gen-2021 | Carr, Bi; Guerra, V; Donghia, R; Farinati, F; Giannini, Eg; Muratori, L; Rapaccini, Gl; Di Marco, M; Caturelli, E; Zoli, M; Sacco, R; Celsa, C; Campani, C; Mega, A; Guarino, M; Gasbarrini, A; Svegliati-Baroni, G; Foschi, Fg; Biasini, E; Masotto, A; Nardone, G; Raimondo, G; Azzaroli, F; Vidili, G; Brunetto, Mr; Trevisani, F. | |
| Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis. | 1-gen-2021 | Brunetto, Mr; Carey, I; Maasoumy, B; Marcos-Fosch, C; Boonstra, A; Caviglia, Gp; Loglio, A; Cavallone, D; Scholtes, C; Ricco, G; Smedile, A; Riveiro-Barciela, M; van Bömmel, F; van der Eijk, A; Zoulim, F; Berg, T; Cornberg, M; Lampertico, P; Agarwal, K; Buti, M | |
| MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE METHODS TO IDENTIFY CLINICAL FEATURES PREDICTIVE OF PROGRESSIVE MAFLD | 1-gen-2021 | Salvati, A; De Rosa, L; Salvati, N; Faita, F; Cavallone, D; Ricco, G; Colombatto, P; Coco, B; Romagnoli, V; Oliveri, F; Bonino, F; Brunetto, Mr | |
| Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. | 1-gen-2021 | Cucchetti, A; Gramenzi, A; Johnson, P; Giannini, Eg; Tovoli, F; Rapaccini, Gl; Marra, F; Cabibbo, G; Caturelli, E; Gasbarrini, A; Svegliati-Baroni, G; Sacco, R; Zoli, M; Morisco, F; Di Marco, M; Mega, A; Foschi, Fg; Biasini, E; Masotto, A; Nardone, G; Raimondo, G; Azzaroli, F; Vidili, G; Brunetto, Mr; Farinati, F; Trevisani, F; Italian Liver Cancer, (ITA. LI. CA) Group. |